There is increasing consumer awareness of the quality, authenticity and health benefits of MASQUELIER’s® French Pine Bark Extract. Professor Masquelier was the first scientist to identify and develop OPCs in tree barks, already well known for their large concentrations of flavonoids. The rich red colour of French Maritime Bark indicated that this species was a prime candidate for OPCs extraction.
This led to the first French plant medicine based on his specific OPCs, manufactured from the bark of the Pinus Maritima tree. The pine bark was harvested from trees grown in the vast “Les Landes” area on the Aquitaine coasts in the southwest of France. In 1951, the very first French Pine Bark Extract patent was registered. More research followed during the 1960s, leading to a second medicine, Flavan® (now known as MASQUELIER’s® French Pine Bark Extract), which is still today administered for its cardiovascular system protective and strengthening properties.
There is increasing consumer awareness of the quality, authenticity and health benefits of MASQUELIER’s® French Pine Bark Extract. Professor Masquelier was the first scientist to identify and develop OPCs in tree barks, already well known for their large concentrations of flavonoids. The rich red colour of French Maritime Bark indicated that this species was a prime candidate for OPCs extraction.
This led to the first French plant medicine based on his specific OPCs, manufactured from the bark of the Pinus Maritima tree. The pine bark was harvested from trees grown in the vast “Les Landes” area on the Aquitaine coasts in the southwest of France. In 1951, the very first French Pine Bark Extract patent was registered. More research followed during the 1960s, leading to a second medicine, Flavan® (now known as MASQUELIER’s® French Pine Bark Extract), which is still today administered for its cardiovascular system protective and strengthening properties.